The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Carcinogenic risks of Psoralen UV‐A therapy and Narrowband UV‐B therapy in chronic plaque psoriasis: a systematic literature review
Abstract
Background Oral 8‐methoxypsoralen–UV‐A (PUVA) and narrowband UV‐B (NB‐UVB or UVB TL‐01) are effective and widely used treatments for chronic plaque psoriasis. Although the role of PUVA therapy in skin carcinogenesis in humans with psoriasis has been clearly demonstrated, there is still controversy regarding the risk of skin cancer with NB‐UVB. Furthermore, there is no clear evidence about the maximum cumulative number of sessions not to be exceeded in a lifetime. Objectives To assess the respective cutaneous carcinogenic risks of PUVA or NB‐UVB in psoriasis; to estimate the respective dose‐relationship between skin cancers and PUVA or NB‐UVB; to estimate a maximum number of sessions for PUVA or NB‐UVB not to be exceeded in a lifetime. Methods A systematic literature search was carried out in Medline, Embase and Cochrane Library databases from1980 to December 2010 in English and French, with the keywords ‘Psoriasis’ AND ‘UVB therapy’ AND ‘UVA therapy’ AND ‘cancer’ AND ‘skin’ OR ‘neoplasm’ OR ‘cutaneous carcinoma’ OR ‘melanoma’. Results Of 243 identified references, 49 published studies were included. Most of them (45/49) concerned PUVA therapy, with 41 assessing the risk of non‐melanoma skin cancers (NMSC) following PUVA. All publications referring to the US prospective PUVA follow‐up study revealed an increased risk of NMSC with the following characteristics: risk most pronounced for squamous cell carcinomas developing even with low exposures and increasing linearly with the number of sessions, tumors occurring also on non‐exposed skin including invasive penile tumors, risk persisting after cessation of treatment. An increased risk of basal cell carcinomas was observed in patients receiving more than hundred PUVA sessions. The four prospective European studies selected in our review and most of the pre‐1990 European and US retrospective studies failed to find a link between exposure to PUVA and skin cancer. Only the most recent cohorts, including three large long‐term retrospective European studies comparing records with their respective national cancer registries reported on an independent increased risk of NMSC with PUVA, The risk was lower as compared to the US prospective PUVA follow‐up study. Six studies assessed the risk of melanoma following PUVA therapy: two of the three US publications coming from the same PUVA prospective follow‐up study revealed an increased risk with more than doubled incidence of both invasive and in situ melanoma among patients exposed to at least 200 PUVA treatments compared with patients exposed to lower doses, whereas the three retrospectives European studies, comparing the incidence of melanoma in PUVA users with national cancer registers, did not find any increased risk of melanoma. No increased risk of skin cancer was evidenced in the four studies specifically assessing the potential carcinogenic risk of NB‐UVB Conclusion There is an increased risk of skin cancer following PUVA, shown by both US and European studies. The greater risk measured by the US studies may be at least partly explained by high UVA dose exposure and the lighter phototypes of the treated patients. The lack of prospective studies in psoriasis patients treated with NB‐UVB constitutes a barrier to the robust assessment of carcinogenic risk of this phototherapy technique.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
Feng, H., Shuda, M., Chang, Y., & Moore, P. S. (2008) · Science · doi:10.1126/science.1152586 · Cited by 3,208
Photochemotherapy of Psoriasis with Oral Methoxsalen and Longwave Ultraviolet Light
Parrish, J. A., Fitzpatrick, T. B., Tanenbaum, L., & Pathak, M. A. (1974) · New England Journal of Medicine · doi:10.1056/nejm197412052912301 · Cited by 1,376
Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
Heath, M., Jaimes, N., Lemos, B., Mostaghimi, A., Wang, L. C., Peñas, P. F., & Nghiem, P. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.11.020 · Cited by 934
Stern, R. S., Nichols, K. T., & Väkevä, L. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361501 · Cited by 656
Cutaneous Squamous-Cell Carcinoma in Patients Treated with PUVA
Stern, R. S., Laird, N., Melski, J., Parrish, J. A., Fitzpatrick, T. B., & Bleich, H. L. (1984) · New England Journal of Medicine · doi:10.1056/nejm198405033101805 · Cited by 452
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.08.026 · Cited by 413
The carcinogenic risk of treatments for severe psoriasis
Stern, R. S., Laird, N., & Study, F. T. P. F.-U. (1994) · Cancer · doi:10.1002/1097-0142(19940601)73:11<2759::aid-cncr2820731118>3.0.co;2-c · Cited by 354
Stern, R. S., & Lange, R. (1988) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12464137 · Cited by 334
Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy
Hearn, R. M. R., Kerr, A. C., Rahim, K. F., Ferguson, J., & Dawe, R. S. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08776.x · Cited by 332
The carcinogenic risk of treatments for severe psoriasis
Dahl, M. V. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90084-5 · Cited by 318
Stern, R. S., & Study*, M. O. T. P. F.-U. (1990) · New England Journal of Medicine · doi:10.1056/nejm199004193221601 · Cited by 307
Stern, R. S., Liebman, E. J., & Väkevä, L. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1278 · Cited by 270
Ibbotson, S. H., Bilsland, D., Cox, N. H., Dawe, R. S., Diffey, B., Edwards, C., Farr, P. M., Ferguson, J., Hart, G., Hawk, J., et al. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06128.x · Cited by 268
PUVA and cancer: a large-scale epidemiological study
LINDELOF, B. (1991) · The Lancet · doi:10.1016/0140-6736(91)90083-2 · Cited by 251
PUVA and cancer risk: the Swedish follow-up study
LindelÖF, Sigurgeirsson, Tegner, LarkÖ, Johannesson, Berne, Ljunggren, Andersson, Molin, Nylander-Lundqvist, et al. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.02928.x · Cited by 236
Stern, R. S., & Lunder, E. J. (1998) · Archives of Dermatology · doi:10.1001/archderm.134.12.1582 · Cited by 230
Maren, W., Blum, A., Frank, E., Röcken, M., & Berneburg, M. (2004) · Acta Dermato-Venereologica · doi:10.1080/00015550410026948 · Cited by 196
Skin tumors in the European PUVA Study
Henseler, T., Christophers, E., Hönigsmann, H., & Wolff, K. (1987) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(87)70010-3 · Cited by 175
Nijsten, T. E. C., & Stern, R. S. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/s0190-9622(03)01587-1 · Cited by 140
Biological effects of narrow-band (311 nm TL01) UVB irradiation: a review
El‐Ghorr, A. A., & Norval, M. (1997) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/s1011-1344(96)07454-4 · Cited by 139
Chuang, T., Heinrich, L. A., Schultz, M. J., Reizner, G. T., Kumm, R. C., & Cripps, D. J. (1992) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(92)70021-7 · Cited by 123
"High single-dose' European PUVA regimen also causes an excess of non-melanoma skin cancer
Bruynzeel, I., Bergman, W., Hartevelt, H. M., KENTER, C. C. A., van der Velde, E. A., Schothorst, A. A., & Suurmond, D. (1991) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1991.tb03281.x · Cited by 117
Carcinogenicity of UVB phototherapy assessed
Young, A. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92617-8 · Cited by 113
Long-term Follow-up of Skin Cancer in the PUVA-48 Cooperative Study
Forman, A. B. (1989) · Archives of Dermatology · doi:10.1001/archderm.1989.01670160063009 · Cited by 108
Cutaneous and ocular side-effects of oral photochemotherapy: results of an 8-year follow-up study
Cox, N. H., Jones, S. K., DOWNEY, D. J., Tuyp, E., Jay, J. L., Moseley, H., & Mackie, R. M. (1987) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1987.tb05805.x · Cited by 101
Keratoses and nonmelanoma skin tumors in long-term photochemotherapy (PUVA)
Hönigsmann, H., Wolff, K. S., Gschnait, F., Brenner, W., & Jaschke, E. (1980) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(80)80336-7 · Cited by 100
Archier, E., Devaux, S., Castela, E., Gallini, A., Aubin, F., Maître, M. L., Aractingi, S., Bachelez, H., Cribier, B. J., Joly, P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04519.x · Cited by 93
Self-citationSkin cancers or premalignant lesions occur in half of high-dose PUVA patients
Lever, L. R., & Farr, P. M. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08494.x · Cited by 85
Paul, C. F., Gallini, A., Archier, E., Castela, E., Devaux, S., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B. J., Joly, P., et al. (2012) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2012.04518.x · Cited by 79
Self-citationCutaneous neoplasia following PUVA therapy for psoriasis
McKenna, K. E., Patterson, C. C., Handley, J., McGinn, S., & Allen, G. (1996) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1996.tb06962.x · Cited by 75
Wulf, H. C., Hansen, A. B., & Bech-Thomsen, N. (1994) · PubMed · Cited by 72
Comparison of the Carcinogenic Potential of Trioxsalen Bath PUVA and Oral Methoxsalen PUVA
Lindelöf, B. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680200051005 · Cited by 71
Skin Tumors in Photochemotherapy for Psoriasis: A Single-Center Follow-Up of 496 Patients
Maier, H., SCHEMPER, M., Ortel, B. J., Binder, M., Tanew, A., & Hönigsmann, H. (2009) · Dermatology · doi:10.1159/000246243 · Cited by 68
PUVA treatment and skin cancer: A follow-up study
Lassus, A., Reunala, T. L., Idänpää-Heikkilä, J., JUVAKOSKI, T., & Salo, O. P. (1981) · Acta Dermato Venereologica · doi:10.2340/0001555561141145 · Cited by 64
Béani, J.-C., & Jeanmougin, M. (2009) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2009.12.004 · Cited by 60
Cutaneous melanomas in patients treated with psoralens plus ultraviolet A
Gupta, A. K., Stern, R. S., Swanson, N. A., Anderson, T. F., & Study, P. F.-U. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70153-x · Cited by 52
Torinuki, W., & Tagami, H. (1988) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(88)70135-8 · Cited by 50
Katz, K. A., Marcil, I., & Stern, R. S. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01769.x · Cited by 50
Skin carcinomas and treatment with photochemotherapy (PUVA)
Lindskov, R. (1983) · Acta Dermato Venereologica · doi:10.2340/0001555563223226 · Cited by 49
Cutaneous carcinoma in psoriatic patients treated with PUVA
Reshad, H., Challoner, F., Pollock, D. J., & Baker, H. (1984) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1984.tb04635.x · Cited by 48
Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
Eskelinen, A., Halme, K., Lassus, A., & Idänpään-Heikkilä, J. J. (1985) · PubMed · Cited by 36
Aubin, F., Puzenat, E., Arveux, P., Louvat, P., Quencez, E., & Humbert, P. G. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04231.x · Cited by 17
Self-citationPUVAthérapie et cancers cutanés
Raiss, M., Templier, I., & Béani, J.-C. (2004) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(04)93636-8 · Cited by 17
THE RELATIONSHIP OF SKIN CANCER TO PUVA THERAPY IN AUSTRALIA
Lobel, E., Paver, K., King, R., Guay, J. L., Poyzer, K. G., & Wargon, O. (1981) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.1981.tb00036.x · Cited by 16
Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler, T., & Christophers, E. (1984) · PubMed · Cited by 10
A Preliminary Study on the Link Between PUVA and Skin Cancer
Chuang, T., Tse, J., & Cripps, D. J. (1989) · International Journal of Dermatology · doi:10.1111/j.1365-4362.1989.tb02501.x · Cited by 7
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Cutaneous melanoma: From pathogenesis to therapy (Review)
Leonardi, G., Falzone, L., Salemi, R., Zangh�, A., Spandidos, D., Mccubrey, J., Candido, S., & Libra, M. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4287 · Cited by 588
Cameron, M. C., Lee, E., Hibler, B. P., Barker, C. A., Mori, S., Cordova, M., Nehal, K. S., & Rossi, A. M. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.03.060 · Cited by 525
Trautinger, F., Eder, J., Assaf, C., Bagot, M., Cozzio, A., Dummer, R., Gniadecki, R., Klemke, C.-D., Ortiz-Romero, P. L., Papadavid, E., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.02.027 · Cited by 452
Papp, K. A., Griffiths, C. E. M., Gordon, K., Lebwohl, M., Szapary, P. O., Wasfi, Y., Chan, D., Hsu, M.-C., Ho, V., Ghislain, P. D., et al. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12214 · Cited by 415
Metadata
- Authors
- Archier, E., Devaux, S., Castela, E., Gallini, A., Aubin, F., Le Maître, M., Aractingi, S., Bachelez, H., Cribier, B., Joly, P., Jullien, D., Misery, L., Paul, C., Ortonne, J. ‐., & Richard, M. ‐.
- Venue
- Journal of the European Academy of Dermatology and Venereology
- Publisher
- Wiley
- Published
- 2012-04-18
- Volume
- 26
- Issue
- s3
- Pages
- 22-31
- ISSN
- 0926-9959 (ISSN-L)
- 1468-3083
- OpenAlex
- W2169053128
- Cited by
- 311
- References
- 46
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.